Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide ; volume:14 ; number:1 ; day:6 ; month:11 ; year:2015 ; pages:1-17 ; date:12.2015
Molecular cancer ; 14, Heft 1 (6.11.2015), 1-17, 12.2015
- Creator
-
Tso, Jonathan L.
- Contributor
-
Yang, Shuai
Menjivar, Jimmy C.
Yamada, Kazunari
Zhang, Yibei
Hong, Irene
Bui, Yvonne
Stream, Alexandra
McBride, William H.
Liau, Linda M.
Nelson, Stanley F.
Cloughesy, Timothy F.
Yong, William H.
Lai, Albert
Tso, Cho-Lea
SpringerLink (Online service)
- DOI
-
10.1186/s12943-015-0459-1
- URN
-
urn:nbn:de:1111-201609044550
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tso, Jonathan L.
- Yang, Shuai
- Menjivar, Jimmy C.
- Yamada, Kazunari
- Zhang, Yibei
- Hong, Irene
- Bui, Yvonne
- Stream, Alexandra
- McBride, William H.
- Liau, Linda M.
- Nelson, Stanley F.
- Cloughesy, Timothy F.
- Yong, William H.
- Lai, Albert
- Tso, Cho-Lea
- SpringerLink (Online service)
Other Objects (12)
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase
Methylierung des O6-Methylguanin-Methyltransferase-Promotors bei Weichgewebesarkomen
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
Verminderte Expression von O6-Methylguanin-DNA-Methyltransferase bei Gliomen durch Promotormethylierung
O6-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis
Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Experimentelle Untersuchungen zur Induktion der O6-Methylguanin-DNA-Methyltransferase an humanen Fibroblasten
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase
Methylierung des O6-Methylguanin-Methyltransferase-Promotors bei Weichgewebesarkomen
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
Verminderte Expression von O6-Methylguanin-DNA-Methyltransferase bei Gliomen durch Promotormethylierung
O6-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis
Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Experimentelle Untersuchungen zur Induktion der O6-Methylguanin-DNA-Methyltransferase an humanen Fibroblasten
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase
Methylierung des O6-Methylguanin-Methyltransferase-Promotors bei Weichgewebesarkomen
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
Verminderte Expression von O6-Methylguanin-DNA-Methyltransferase bei Gliomen durch Promotormethylierung
O6-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis
Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Experimentelle Untersuchungen zur Induktion der O6-Methylguanin-DNA-Methyltransferase an humanen Fibroblasten